NewsRx

Search our medical news database

Thyroid Disease

Endocrinologists applaud FDA confirmation of safety, efficacy of Synthroid

Published in Drug Week, September 6th, 2002

Millions of patients and their endocrinologists have relied on Synthroid (levothyroxine) for decades to maintain their thyroid health.

That Synthroid has received FDA approval is welcomed news for the members of the American Association of Clinical Endocrinologists (AACE) and the patients they treat.

In June 2001, the FDA notified Abbott Laboratories, makers of Synthroid that either a new drug application (NDA) must be filed or that evidence must be submitted to show that the product is not a new drug and is generally recognized as safe and effective. At this time AACE encouraged patients to not switch medications unless warranted by their...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook